KONFIDO: An Innovative View of eHealth Security

The Horizon 2020 funded KONFIDO Action concluded its activities related to User Requirement Analysis. This initial phase of the Action entailed a gap analysis study about secure and interoperable solutions at the systemic level, the definition and analysis of user scenarios, the user requirements elicitation, and an intense interaction with the KONFIDO end-users (both patients/citizens and healthcare professionals) for the identification of barriers and facilitators concerning eHealth acceptance coupled with cybersecurity technologies. This phase set the basis for designing a secure and interoperable toolkit capable of fostering cross-border exchange of health data within the European Union that KONFIDO aims to develop.

"Without a clear, comprehensive and thorough analysis of user requirements, the failure of any eHealth project is predetermined," said Dr. Vassilis Koutkias (the Researcher with the Institute of Applied Biosciences, Centre for Research & Technology Hellas - CERTH, Thessaloniki, Greece, who led the User Requirement Analysis activities), "so our approach was to move fast to identify the challenges for such a development, and provide useful input for the design of the KONFIDO solution. Apparently, this solution will not rely only on technological foundations/advancements, but also on organisational, legal and human aspects."

The lack of understanding users, their needs and the environment in which a new technology is to be applied is a frequent failure factor for eHealth projects. Instead, stakeholder engagement from the very beginning can have positive effects. To this end, the KONFIDO gap analysis study reviewed and mapped relevant technical and legal frameworks as well as ethical and social norms at the EU level. Secondly, it defined and analysed user scenarios with an emphasis on cross-border health data exchange and, based on these, it conducted a user requirements elicitation phase starting from the definition of the underlying business processes and proceeding to the identification of threats, assets and, ultimately, high-level user goals. Finally, pursuing intense interaction with the broader eHealth ecosystem, KONFIDO identified a set of barriers and facilitators for eHealth acceptance linked with cybersecurity, by conducting a pan-European survey involving all relevant stakeholders, i.e. healthcare professionals, health Information Technologies developers, industrial stakeholders and patients/citizens, and two Workshops, which validated the methods and the outcomes of the approach.

For further information, please visit:
http://konfido-project.eu

About KONFIDO Action

The 36-month KONFIDO H2020 project exploits proven tools and processes, as well as new cutting-edge technologies and approaches to create a scalable and holistic example for secure internal and cross-border exchange, storage and overall healthcare data management in a legal and ethical way, both at national and European level. The KONFIDO consortium consists of 15 partners with complementary expertise and roles from seven European countries, including technology providers, universities, research institutes and end-users.

Most Popular Now

Welcome Evo, Generative AI for the Genom…

Brian Hie runs the Laboratory of Evolutionary Design at Stanford, where he works at the crossroads of artificial intelligence and biology. Not long ago, Hie pondered a provocative question: If...

Research Study Shows the Cost-Effectiven…

Earlier research showed that primary care clinicians using AI-ECG tools identified more unknown cases of a weak heart pump, also called low ejection fraction, than without AI. New study findings...

Remote Telemedicine Tool Found Highly Ac…

Collecting images of suspicious-looking skin growths and sending them off-site for specialists to analyze is as accurate in identifying skin cancers as having a dermatologist examine them in person, a...

New Study Reveals Why Organisations are …

The slow adoption of blockchain technology is partly driven by overhyped promises that often obscure the complex technological, organisational, and environmental challenges, according to research from the University of Surrey...

Almost All Leading AI Chatbots Show Sign…

Almost all leading large language models or "chatbots" show signs of mild cognitive impairment in tests widely used to spot early signs of dementia, finds a study in the Christmas...

Philips Aims to Advance Cardiac MRI Tech…

Royal Philips (NYSE: PHG, AEX: PHIA) and Mayo Clinic announced a research collaboration aimed at advancing MRI for cardiac applications. Through this investigation, Philips and Mayo Clinic will look to...

Deep Learning Model Accurately Diagnoses…

Using just one inhalation lung CT scan, a deep learning model can accurately diagnose and stage chronic obstructive pulmonary disease (COPD), according to a study published today in Radiology: Cardiothoracic...

Shape-Changing Device Helps Visually Imp…

Researchers from Imperial College London, working with the company MakeSense Technology and the charity Bravo Victor, have developed a shape-changing device called Shape that helps people with visual impairment navigate...

Bayer Acquires HiDoc Technologies and Ca…

Bayer is today announcing that it plans to acquire HiDoc Technologies GmbH in the first quarter of 2025 and to start commercialization of the digital health application, Cara Care®. Cara...

AI-Based Chatbot Created for Bioimage An…

Scientists from Universidad Carlos III de Madrid (UC3M), together with a research team from Ericsson and the KTH Royal Institute of Technology in Sweden, have developed an artificial intelligence-based software...

Analyzing Multiple Mammograms Improves B…

A new study from Washington University School of Medicine in St. Louis describes an innovative method of analyzing mammograms that significantly improves the accuracy of predicting the risk of breast...

Emotional Cognition Analysis Enables Nea…

A joint research team from the University of Canberra and Kuwait College of Science and Technology has achieved groundbreaking detection of Parkinson's disease with near-perfect accuracy, simply by analyzing brain...